Caress Flow, a groundbreaking treatment that promises to transform the management of vaginal pathologies, is now available in the UK. The innovative therapy offers a holistic, painless solution to a range of vaginal symptoms, with clinical evidence demonstrating significant benefits, including for breast cancer survivors.
Caress Flow distinguishes itself from other treatments on the market with its non-invasive, painless approach that requires no post-procedure downtime. Unlike traditional methods such as lasers or radiofrequency, Caress Flow utilises a unique combination of oxygen and hyaluronic acid to rejuvenate and heal vaginal tissues naturally. This method promotes tissue regeneration, improves elasticity, and enhances overall vaginal health without the need for harsh chemicals or painful procedures.
Treats six common conditions
Caress Flow is designed to address six prevalent vaginal conditions:
- Urinary incontinence – 81% reduction of incontinence
- Recurrent candidiasis – 94% absence of recurrent candidiasis after three months and 83% absence of the current candidiasis after six months
- Vestibulitis – 79% decreased itching and 79% reduction of injuries
- Lichen sclerosis – 83% pain relief and 83% decreased itching
- Vulvo-vaginal atrophy – 85% decreased burning and 81% increased fluidity
- Urethral burn – 82% decreased burning.
By providing a non-hormonal, natural alternative, Caress Flow eliminates the need for ongoing use of vaginal creams, offering a simpler, more effective solution for women.
Affordable and accessible
In addition to its clinical efficacy, Caress Flow is also an affordable treatment option, making it accessible to a wider audience. With lower costs compared to traditional laser and radiofrequency treatments and without the need for follow-up creams or additional procedures, Caress Flow is poised to become the go-to solution for women seeking effective and economical care.
Clinically proven benefits for breast cancer patients
A recent study published in Climacteric highlights the effectiveness of Caress Flow in treating genito-urinary symptoms among breast cancer survivors. The study showed that after five treatments, patients experienced a substantial improvement in vaginal health, with 85% of participants reporting reduced pain and increased comfort during intercourse. These results remained consistent even 30 days after the last treatment, making Caress Flow a reliable option for long-term relief [1].
FURTHER INFORMATION:
Reference
1. Massarotti C, et al. Vaginal oxygen plus hyaluronic acid on genito-urinary symptoms of breast cancer survivors. Climacteric 2023;26(2):129–34.
